Abstract
Introduction: Phosphate ion is common in the core of urinary stones and may initiate stone formation. However, the precise role of phosphate in the initiation of stone formation remains obscure. We assessed the effects of dietary phosphate load on urinary stone risk and phosphate metabolism. Methods: Ten non-stone-forming healthy volunteers completed this randomized, crossover study. Each subject was provided a high- or low-phosphate diet for 3 days. After a 2-day equilibration period with a moderate-phosphate diet, the participants received a low- or high-phosphate diet for another 3 days. Serum, fecal, and 24-h urine samples were collected at the end of each intervention. Results: High dietary phosphate load increased urinary phosphate excretion, and low dietary phosphate decreased urinary phosphate excretion. In addition, urine pH was lower and supersaturation (SS) index of uric acid (UA) was higher after a high-phosphate diet. There was no significant difference in the SS index for calcium oxalate, brushite and hydroxyapatite, or 24-h urinary citrate between the high and the low dietary phosphate. Also, no significant change was observed in fecal phosphate excretion after a high- or low-phosphate diet. The serum phosphate level increased after a high-phosphate diet, but there was no difference in serum phosphate between low-phosphate and moderate-phosphate diets. Conclusion: High dietary phosphate load led to higher urinary phosphate excretion, a higher SS index of UA, and lower urine pH. Stone formers should be advised to limit the intake of high-phosphate source diet, including high-protein diets and phosphate-based food additives.
Journal Section:
Clinical Study
References
1.
Abufaraj
M
, Al Karmi
J
, Yang
L
. Prevalence and trends of urolithiasis among adults
. Curr Opin Urol
. 2022
;32
(4
):425
–32
. 2.
Achilles
W
, Jockel
U
, Schaper
A
, Burk
M
, Riedmiller
H
. In vitro formation of “urinary stones”: generation of spherulites of calcium phosphate in gel and overgrowth with calcium oxalate using a new flow model of crystallization
. Scanning Microsc
. 1995
;9
(2
):577
–86
.3.
Walker
V
. Phosphaturia in kidney stone formers: still an enigma
. Adv Clin Chem
. 2019
;90
:133
–96
. 4.
Calvo
MS
, Moshfegh
AJ
, Tucker
KL
. Assessing the health impact of phosphorus in the food supply: issues and considerations
. Adv Nutr
. 2014
;5
(1
):104
–13
. 5.
Fulgoni
VL
3rd, Keast
DR
, Bailey
RL
, Dwyer
J
. Foods, fortificants, and supplements: where do Americans get their nutrients
. J Nutr
. 2011
;141
(10
):1847
–54
. 6.
Peacock
M
. Phosphate metabolism in health and disease
. Calcif Tissue Int
. 2021
;108
(1
):3
–15
. 7.
Cooke
A
. Dietary food-additive phosphate and human health outcomes
. Compr Rev Food Sci Food Saf
. 2017
;16
(5
):906
–1021
. 8.
Vorland
CJ
, Martin
BR
, Weaver
CM
, Peacock
M
, Hill Gallant
KM
. Phosphorus balance in adolescent girls and the effect of supplemental dietary calcium
. JBMR Plus
. 2018
;2
:103
–8
. 9.
Mackay
EM
, Oliver
J
. Renal damage following the ingestion of a diet containing an excess of inorganic phosphate
. J Exp Med
. 1935
;61
(3
):319
–34
. 10.
Chang
AR
, Anderson
C
. Dietary phosphorus intake and the kidney
. Annu Rev Nutr
. 2017
;37
:321
–46
. 11.
Siener
R
, Netzer
L
, Hesse
A
. Determinants of brushite stone formation: a case-control study
. PLoS One
. 2013
;8
(11
):e78996
. 12.
Beck
L
, Karaplis
AC
, Amizuka
N
, Hewson
AS
, Ozawa
H
, Tenenhouse
HS
. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities
. Proc Natl Acad Sci U S A
. 1998
;95
(9
):5372
–7
. 13.
Bergwitz
C
, Roslin
NM
, Tieder
M
, Loredo-Osti
JC
, Bastepe
M
, Abu-Zahra
H
, et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis
. Am J Hum Genet
. 2006
;78
(2
):179
–92
. 14.
Bijvoet
OL
, Morgan
DB
, Fourman
P
. The assessment of phosphate reabsorption
. Clin Chim Acta
. 1969
;26
(1
):15
–24
. 15.
Thomas
L
, Bettoni
C
, Knopfel
T
, Hernando
N
, Biber
J
, Wagner
CA
. Acute adaption to oral or intravenous phosphate requires parathyroid hormone
. J Am Soc Nephrol
. 2017
;28
(3
):903
–14
. 16.
Jozefacki
A
, White
CA
, Shobeiri
NS
, Hopman
WM
, Johri
AM
, Adams
MA
, et al. Phosphate excretion is decreased in older cardiac patients with normal kidney function: an emerging dietary risk factor
. Appl Physiol Nutr Metab
. 2016
;41
(4
):452
–5
. 17.
Llach
F
, Massry
SG
. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency
. J Clin Endocrinol Metab
. 1985
;61
(4
):601
–6
. 18.
Hegsted
M
, Schuette
SA
, Zemel
MB
, Linkswiler
HM
. Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake
. J Nutr
. 1981
;111
(3
):553
–62
. 19.
King
JS
, Nordin
BEC
, Livingstone
C
. Metabolic bone and stone disease
. Clin Chem
. 1974
;5
:634
–5
.20.
Farell
G
, Huang
E
, Kim
SY
, Horstkorte
R
, Lieske
JC
. Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals
. J Am Soc Nephrol
. 2004
;15
(12
):3052
–62
. 21.
Grases
F
, Costa-Bauza
A
, Gomila
I
, Ramis
M
, Garcia-Raja
A
, Prieto
RM
. Urinary pH and renal lithiasis
. Urol Res
. 2012
;40
(1
):41
–6
. 22.
Gao
J
, Xue
JF
, Xu
M
, Gui
BS
, Wang
FX
, Ouyang
JM
. Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites
. Int J Nanomedicine
. 2014
;9
:4399
–409
. 23.
Trautvetter
U
, Jahreis
G
, Kiehntopf
M
, Glei
M
. Consequences of a high phosphorus intake on mineral metabolism and bone remodeling in dependence of calcium intake in healthy subjects - a randomized placebo-controlled human intervention study
. Nutr J
. 2016
;15
:7
. 24.
Byrne
FN
, Gillman
B
, Kiely
M
, Bowles
M
, Connolly
P
, Earlie
J
, et al. Revising dietary phosphorus advice in chronic kidney disease G3-5D
. J Ren Nutr
. 2021
;31
(2
):132
–43
. 25.
Quarles
LD
. Endocrine functions of bone in mineral metabolism regulation
. J Clin Invest
. 2008
;118
(12
):3820
–8
. 26.
Larsson
T
, Nisbeth
U
, Ljunggren
O
, Juppner
H
, Jonsson
KB
. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
. Kidney Int
. 2003
;64
(6
):2272
–9
. 27.
Ferrari
SL
, Bonjour
JP
, Rizzoli
R
. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men
. J Clin Endocrinol Metab
. 2005
;90
(3
):1519
–24
. 28.
Kremsdorf
RA
, Hoofnagle
AN
, Kratz
M
, Weigle
DS
, Callahan
HS
, Purnell
JQ
, et al. Effects of a high-protein diet on regulation of phosphorus homeostasis
. J Clin Endocrinol Metab
. 2013
;98
(3
):1207
–13
. 29.
Vervloet
MG
, van Ittersum
FJ
, Buttler
RM
, Heijboer
AC
, Blankenstein
MA
, ter Wee
PM
. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23
. Clin J Am Soc Nephrol
. 2011
;6
(2
):383
–9
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
